(CTVA) Corteva - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US22052L1044

CTVA EPS (Earnings per Share)

This chart shows the EPS (Earnings per Share) of CTVA over the last 5 years for every Quarter.

CTVA Revenue

This chart shows the Revenue of CTVA over the last 5 years for every Quarter.

CTVA: Seeds, Herbicides, Insecticides, Fungicides, Nitrogen Stabilizers

Corteva Inc (NYSE:CTVA) is a leading player in the agriculture industry, operating through two primary segments: Seed and Crop Protection. The company leverages cutting-edge technology to develop and supply high-quality seeds and crop protection products, enabling farmers to optimize yields, reduce losses, and improve profitability. By providing innovative trait technologies, digital solutions, and a range of crop protection products, Corteva helps farmers tackle pressing challenges such as weather resistance, disease management, and weed control.

The Seed segment is a key driver of Cortevas growth, offering advanced germplasm and traits that enhance crop resilience and nutritional value. The companys digital solutions also empower farmers to make informed decisions, maximizing yield and profitability. Meanwhile, the Crop Protection segment provides a comprehensive portfolio of products, including herbicides, insecticides, and nitrogen stabilizers, to safeguard crops against pests, diseases, and weeds. With a global presence spanning the Americas, Asia Pacific, Europe, the Middle East, and Africa, Corteva is well-positioned to capitalize on the growing demand for agricultural inputs.

From a technical analysis perspective, CTVAs stock price has been trending upwards, with the short-term SMA20 (67.80) and long-term SMA200 (60.10) indicating a bullish outlook. The Average True Range (ATR) of 1.29 suggests moderate volatility, with a daily price movement of around 1.82%. Given the current price of 70.95, near the 52-week high, we can expect some consolidation or correction in the near term. However, the overall trend remains positive, with potential for further growth.

Fundamentally, Cortevas market capitalization stands at approximately $47.1 billion, with a forward P/E ratio of 24.33 indicating moderate growth expectations. The companys Return on Equity (RoE) of 4.65% suggests room for improvement in terms of profitability. Nevertheless, Cortevas diversified product portfolio, global reach, and commitment to innovation position the company for long-term success. Based on the technical and fundamental data, our forecast suggests that CTVA will continue to trend upwards, potentially reaching $75-$80 in the next 6-12 months, driven by the growing demand for agricultural inputs and the companys innovative product offerings.

Additional Sources for CTVA Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

CTVA Stock Overview

Market Cap in USD 49,962m
Sector Basic Materials
Industry Agricultural Inputs
GiC Sub-Industry Fertilizers & Agricultural Chemicals
IPO / Inception 2019-05-24

CTVA Stock Ratings

Growth Rating 82.5
Fundamental 11.4
Dividend Rating 57.3
Rel. Strength 37.9
Analysts 4.29 of 5
Fair Price Momentum 79.78 USD
Fair Price DCF 36.95 USD

CTVA Dividends

Dividend Yield 12m 1.01%
Yield on Cost 5y 2.62%
Annual Growth 5y 4.88%
Payout Consistency 100.0%
Payout Ratio 24.4%

CTVA Growth Ratios

Growth Correlation 3m 94.3%
Growth Correlation 12m 85.5%
Growth Correlation 5y 73%
CAGR 5y 23.47%
CAGR/Max DD 5y 0.68
Sharpe Ratio 12m 0.31
Alpha 27.11
Beta 0.780
Volatility 25.97%
Current Volume 1927.4k
Average Volume 20d 3650.2k
What is the price of CTVA shares?
As of July 01, 2025, the stock is trading at USD 74.53 with a total of 1,927,350 shares traded.
Over the past week, the price has changed by +0.12%, over one month by +5.05%, over three months by +18.72% and over the past year by +41.98%.
Is Corteva a good stock to buy?
Neither. Based on ValueRay´s Fundamental Analyses, Corteva is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 11.35 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CTVA is around 79.78 USD . This means that CTVA is currently overvalued and has a potential downside of 7.04%.
Is CTVA a buy, sell or hold?
Corteva has received a consensus analysts rating of 4.29. Therefor, it is recommend to buy CTVA.
  • Strong Buy: 13
  • Buy: 5
  • Hold: 6
  • Sell: 0
  • Strong Sell: 0
What are the forecasts for CTVA share price target?
According to our own proprietary Forecast Model, CTVA Corteva will be worth about 90.8 in July 2026. The stock is currently trading at 74.53. This means that the stock has a potential upside of +21.78%.
Issuer Target Up/Down from current
Wallstreet Target Price 73.8 -0.9%
Analysts Target Price 73.1 -1.9%
ValueRay Target Price 90.8 21.8%